Back to speakers

Graham FOSTER

Professor

UK

City: London

Institution: Professor of Hepatology, QMUL

Contact: g.r.foster@qmul.ac.uk


Biography of Graham FOSTER

Professor Foster is the Professor of Hepatology at Queen Marys, University of London and a consultant at Barts Health in East London. He trained in Medicine at Oxford and London Universities in the 1980s and completed a PhD in Molecular Biology in 1992. Professor Foster has a long-standing interest in the management of chronic liver disorders, with particular reference to viral hepatitis and runs a clinical research program studying the natural history of viral hepatitis, its impact upon patients and their communities and novel therapies for this disease. He has led national studies investigating community screening for viral hepatitis and supervises a laboratory research program investigating novel replication models for hepatitis C. He is the editor of The Journal of Viral Hepatitis and has published widely in the field of viral liver disease and remains committed to the global elimination of hepatitis C.

PHC's participations

Monday, March 08th 2021

TAKE HOME MESSAGES (chairman)

Tuesday, March 09th 2021

IS ELIMINATION OF HCV BY 2030 REALISTIC (chairman)

12th PHC – 2019

Monday, January 14th 2019

Is there still a role for personalized treatment? -

HEPATITIS C - SESSION 2 (chairman)

3rd PHC – 2009

Monday, January 19th 2009

Optimizing therapy in real life illustrated with clinical cases (chairman)

5th PHC – 2012

Monday, January 30th 2012

Interactive luncheons - Room 3 (chairman)

Interactive luncheons - Room 3 -

Genotype 3 -

Tuesday, January 31st 2012

Lead in or no lead in ? (chairman) -

6th PHC – 2013

Monday, January 14th 2013

Genotype 3 -

Interactive luncheons - Room 3 (chairman)

Controversy: F1/F2 patients: treat or wait? (chairman)

7th PHC – 2014

Monday, January 13th 2014

Personalized treatment with telaprevir -

How to optimize current therapy of non G1 patients (chairman)

11th PHC – 2018

Monday, January 15th 2018

Cost benefit of treatment in F1 patients -

Luncheon workshops - (chairman)

- Speakers: (chairman)

10th PHC – 2017

Monday, January 30th 2017

LUNCH WORKSHOPS - 2-How to optimize treatment in G3 patients (chairman)

AROUND THE WORLD TABLE: ACCESS TO THERAPY - WESTERN COUNTRIES -

Tuesday, January 31st 2017

TWO PROGRAMS OF HCV ERADICATION (chairman)

8th PHC – 2015

Monday, January 12th 2015

Why genotype 3 is difficult to cure? -

9th PHC – 2016

Monday, January 11th 2016

Individual optimization of therapy (shorten therapy) -

How to improve access to therapy? Around the World table - NORTH & WEST -

Lunch Workshops - Room 242A (chairman)